La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zhejiang Wolwo Bio-Pharmaceutical Bilan de santé
Santé financière contrôle des critères 5/6
Zhejiang Wolwo Bio-Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥49.2M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥2.6B and CN¥241.2M respectively. Zhejiang Wolwo Bio-Pharmaceutical's EBIT is CN¥315.0M making its interest coverage ratio -10.5. It has cash and short-term investments of CN¥1.3B.
Informations clés
2.1%
Ratio d'endettement
CN¥49.17m
Dette
| Ratio de couverture des intérêts | -10.5x |
| Argent liquide | CN¥1.28b |
| Fonds propres | CN¥2.38b |
| Total du passif | CN¥241.17m |
| Total des actifs | CN¥2.62b |
Mises à jour récentes de la santé financière
Recent updates
Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185
Jun 30
Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking
May 27Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)
May 07Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?
Mar 22Analyse de la situation financière
Passif à court terme: 300357's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥161.9M).
Passif à long terme: 300357's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥79.3M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 300357 has more cash than its total debt.
Réduire la dette: 300357's debt to equity ratio has increased from 0% to 2.1% over the past 5 years.
Couverture de la dette: 300357's debt is well covered by operating cash flow (695.4%).
Couverture des intérêts: 300357 earns more interest than it pays, so coverage of interest payments is not a concern.